Axa’s ScottsMiracle-Gro SMG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-67,600
Closed -$6.05M 1359
2017
Q2
$6.05M Buy
+67,600
New +$6.09M 0.03% 560
2016
Q3
Sell
-102,500
Closed -$7.17M 1329
2016
Q2
$7.17M Buy
+102,500
New +$7.12M 0.03% 479
2015
Q3
Sell
-10,800
Closed -$639K 1510
2015
Q2
$639K Sell
10,800
-44,400
-80% -$2.82M ﹤0.01% 1034
2015
Q1
$3.71M Sell
55,200
-20,200
-27% -$1.32M 0.02% 665
2014
Q4
$4.7M Buy
75,400
+69,900
+1,271% +$4.16M 0.02% 574
2014
Q3
$303K Buy
+5,500
New +$309K ﹤0.01% 1172

Other funds holding SMG

Axa's SMG Position: Q3 2017 in Review

Axa sold out of ScottsMiracle-Gro (SMG) in Q3 2017, closing a stake of 67,600 shares — an estimated $6.05M sold.

Axa first reported a position in SMG in Q3 2014 and held it in 6 quarters. The position peaked at $7.17M in Q2 2016. 322 funds tracked by Wall St. Rank hold SMG as of Q3 2017.

  • Axa reported no remaining ScottsMiracle-Gro position as of Q3 2017 after selling out during the quarter.
  • Axa sold 67,600 ScottsMiracle-Gro shares in Q3 2017, an estimated $6.05M.
  • Axa first reported a position in ScottsMiracle-Gro in Q3 2014 and held it in 6 quarters.
  • Axa's ScottsMiracle-Gro position peaked at $7.17M in Q2 2016.
  • 322 funds tracked by Wall St. Rank held ScottsMiracle-Gro as of Q3 2017.

Based on Axa's 13F filing for Q3 2017, filed 13 Nov 2017.